Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ENA |
---|---|---|
01:44 ET | 500 | 1.14 |
01:55 ET | 500 | 1.14 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Enablence Technologies Inc | 21.4M | -1.4x | --- |
Rapid Dose Therapeutics Corp | 27.8M | -6.7x | --- |
Sona Nanotech Inc | 36.2M | -11.9x | --- |
NuGen Medical Devices Inc | 21.3M | -1.6x | --- |
Gemina Laboratories Ltd | 39.6M | -5.9x | --- |
Lattice Biologics Ltd | 4.1M | -3.9x | --- |
Enablence Technologies Inc. is a Canada-based company that designs, manufactures and sells optical components, primarily in the form of planar lightwave circuits (PLC), on silicon-based chips. The Company's products serve a global customer base, primarily focused on data center and other end markets. It also works with customers that have emerging market uses for its technology, including medical devices, automotive light detection and ranging (LiDAR) and virtual and augmented reality headsets. The Company also uses a non-captive fabrication plant in Fremont, California to manufacture chips designed by third party customers. The Company's products include coarse wavelength division multiplexing, dense wavelength division multiplexing, LAN-wavelength division multiplexing, ultra-long delay lines, custom fab services and custom design services. Its technology includes advanced signal processing, artificial intelligence and machine learning chip design and coherent optics, among others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $21.4M |
---|---|
Revenue (TTM) | $2.1M |
Shares Outstanding | 18.8M |
Enablence Technologies Inc does not pay a dividend. | |
Beta | 1.18 |
EPS | $-0.80 |
Book Value | $-0.95 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 10.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -574.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.